See shared care guideline for immunomodulating drugs
Sulfasalazine plain tabs are licensed to treat ulcerative colitis and crohn's disease.
Sulfasalazine EC tabs are licensed to treat ulcerative colitis, crohn's disease and rheumatoid arthritis.
Salazopyrin is the preferred cost-effective brand. (Decision date - April 2023)